ArticleBiomarker research2026

Genome-wide biomarker analysis across the full spectrum of HER2-expressing breast cancers to reveal a clonal chromosome 17 imbalance defining unfavourable HER2-low disease.

Sara Erika Bellomo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.